Skip to main content
Log in

Antihypertensive therapy with a single daily dose of acebutolol in essential hypertension, response and ophthalmological assessment in the Japanese

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Twenty patients with essential hypertension were given 400 mg acebutolol once daily for 24 weeks. In order to study if side effects resembling the “Practolol syndrome” developed, ocular effects were sought and antinuclear antibody (ANA) in blood was assessed before and after treatment. ANA was negative both before and after the study in 17 patients; in one patient ANA was positive, but the titre (1:10) was low and did not change during the study. Acebutolol produced no undesirable effects on cornea, conjunctiva or lens. During acebutolol treatment, tear secretion was reduced but tear lysozyme concentration was not significantly altered. Overall, acebutolol had no undesirable action similar to the practolol-induced syndrome, nor did it cause such common clinical ocular symptoms such as dry or gritty eyes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Booth RJ, Willson JD, Bullock JY (1982)β-Adrenergic receptor blockers and antinuclear antibodies in hypertension. Clin Pharmacol Ther 31: 555–558

    Google Scholar 

  • Cody RJ, Calabrese LH, Clough JD, Tarazi RC, Bravo EL (1979) Development of antinuclear antibodies during acebutolol therapy. Clin Pharmacol Ther 25: 800–805

    Google Scholar 

  • Cubey RB, Taylor SH (1975) Ocular reaction to propranolol and resolution on continued treatment with different beta-blocking drug. Br Med J 4: 327–328

    Google Scholar 

  • Felix RH, Ive FA, Dahl MGC (1974) Cutaneous and ocular reactions to practolol. Br Med J 4: 321–324

    Google Scholar 

  • Friou GI (1957) Clinical application of lupus serum-nucleoprotein reaction using fluorescent antibody technique. J Clin Invest 36: 890

    Google Scholar 

  • Mackie IA, Seal DV, Pescod JM (1977) Beta-adrenergic receptor blocking drugs: tear lysozyme and immunological screening for adverse reaction. Br J Ophthalmol 61: 354–359

    Google Scholar 

  • Raftery EB, Denman AM (1973) Systemic lupus erythematosus syndrome induced by practolol. Br Med J 2: 452–455

    Google Scholar 

  • Richardson PJ, Tee DEH, Oram S (1975) Oculocutaneous reactions to beta-blocking drugs. Br Med J 4: 648

    Google Scholar 

  • Shapiro A, Kimchi A, Gotsman MS, Lewis BS (1980) Ocular effects of acebutolol and propranolol. Met Ped Ophthalmol 4: 87–88

    Google Scholar 

  • Wright P (1975) Untoward effects associated with practolol administration: oculomucocutaneous syndrome. Br Med J 1: 595–598

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sekine, K., Takahashi, M., Ogata, E. et al. Antihypertensive therapy with a single daily dose of acebutolol in essential hypertension, response and ophthalmological assessment in the Japanese. Eur J Clin Pharmacol 28, 709–711 (1985). https://doi.org/10.1007/BF00607921

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00607921

Key words

Navigation